A New Patient-centric Outcome Measure for Patients With Hemophilia: Testing the Feasibility of GAS-Hem in Pediatric, Adolescent and Adult Hemophilia A Patients
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Rurioctocog alfa (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Sponsors Baxalta; Shire
- 30 Nov 2016 Status changed from active, no longer recruiting to completed.
- 16 Aug 2016 Planned End Date changed from 1 Aug 2016 to 1 Nov 2016.
- 16 Aug 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Nov 2016.